Cite
MLA Citation
John Marshall et al.. “Phase I dose-escalation study of afatinib, an ErbB family blocker, plus docetaxel in patients with advanced cancer.” Future oncology, vol. 9, 2013, pp. 271–281. http://access.bl.uk/ark:/81055/vdc_100134018080.0x00000c